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Summary This report presents the results of a study into the effect of breast self-examination (BSE) in a
large defined population within the City of Nottingham since 1979. We have examined the effect of breast
self-examination in a group of patients invited to attend for education in BSE compared with a group of
historical controls. No overall survival advantage has been demonstrated for the study group but within the
latter group patients who had attended for instruction in BSE had a significantly better actuarial survival at
13 years than those who did not (P<0.001). Patients in the study group presented with significantly smaller
tumours which were more likely to be of better histological grade and lymph node stage. A case-control
study has demonstrated the value of attendance for BSE particularly in post-menopausal women. Although
BSE is not as sensitive as mammographic screening, patients who practise it present with more favourable
tumour characteristics and its value in post-menopausal women supports its use as an adjunct to
mammographic screening.
An education programme for BSE was established in
Nottingham in 1979 as part of the National Trial of the
Early Detection of Breast Cancer (UK Trial, 1981). The
South Nottingham health district was selected and women in
this district between 45 and 64 years old were invited to
attend for education in BSE (Dowle et al., 1987) at the
Breast Screening Unit at the General Hospital, Nottingham
(BSUGHN). Women who attended the BSE sessions could
self-refer to the unit if they subsequently found any
abnormality in the breasts.
In 1981 a similar project was started in the North
Nottingham health district with money provided by a
charity, the Nottinghamshire Breast Cancer Screening Trust.
In this study women between 40 and 65 years were invited to
attend BSE sessions at the Helen Garrod Breast Screening
Unit (HGBSU), City Hospital, or in local community halls
and health centres. Subsequently they could self-refer to the
unit with any abnormality they found in the breast
(Caseldine et al., 1988).
This is a report of the combined results; it comprises the
report of mortality from breast cancer in a large defined
population educated in BSE compared with mortality in the
same population prior to BSE education.
Methods
Study population
The two 'study' population cohorts were identified from the
family practitioner committee (FPC) register, which lists
women living in Nottingham according to the general
practitioner (GP) with whom they are registered; trial lists
for each district were compiled. All women in the identified
age groups were invited by personal letter, sent on behalf of
their GP, to attend education sessions given by specially
trained nursing sisters (BSUGHN) and radiographers
(HGBSU). This consisted of a talk and film with ample time
for discussion afterwards; emphasis was placed on both
visible and physical signs. The need for regular systematic
and thorough examination of each breast every month and
the necessity to report immediately any changes noticed were
emphasised.
Self-referral clinics
The self-referral clinics were established by agreement with
the local medical committees. The offices of the units are
open five days a week for administrative work. The self-
referral clinics are only held on certain days of the week, but
women usually receive an appointment within two days.
On attending the self-referral clinics, the patients were
examined by the nursing sisters or radiographers who had
given the education sessions and a two view mammogram
was taken (cranio-caudal and 450 medio-lateral oblique). The
radiographers made an initial report on the mammograms
which were checked once a week by the consultant
radiologists (Dr E.J. Roebuck (BSUGHN), and successively
Drs Morris, Glaves and Manhire (HGBSU)). If both the
clinical examination and the mammogram were normal the
patient was reassured and discharged without being
examined by medically qualified staff and the GP was
informed. Any patient with a suspicious clinical or
mammographic abnormality was assessed by the clinic
surgeon (successively Drs H.W. Holliday, P. Doyle, C.P.
Hinton, C.S. Dowle and A.P. Locker) who was a member of
a specialist breast surgical team at the City Hospital.
Some patients were kept under clinical review for a 6-
month period, being examined twice in that time, after which
a further mammogram was taken and the patient was either
discharged or referred for surgery; at this time the GP was
notified of the decision. This procedure ensured that all
women self-referring were either reassured and discharged or
referred for surgical intervention, and a clear recommendation
reached the GP.
Case-control study
We have conducted a case-control study where every patient
dying from breast cancer in the study population between
the time of receiving their original invitation and December
1987 was age-matched with three controls who had not died
from breast cancer. Controls were women in the same age
group and general practice lists and who had been sent an
invitation for BSE education. Both the patients dying from
breast cancer and the case controls were checked on the
registers to see whether they had attended for BSE education
or not. Those women dying from breast cancer were
identified by searching the weekly death notifications from
the Registrar of Births, Deaths and Marriages, which were
checked against the population registers. As the death
notifications included the cause of death these were carefully
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scrutinised to identify correctly the breast cancer deaths and
breast cancer patients.
The case-control study was divided into pre- and post-
menopausal groups, taking age at diagnosis of breast cancer
between 40 and 50 as premenopausal and 51 + as
post-menopausal.
Case fatality
Since this was not a randomised controlled trial we have
taken a group of 'historical controls' which has been
compared with the 'study population'. The study population
is the number of women who developed breast cancer
following a letter of invitation to a BSE class, irrespective of
whether they attended or not (n=751). The study population
was recognised from careful searching of pathology
daybooks, theatre lists and cancer and death registers.
The 'historical control' population was derived
retrospectively from the Trent Regional Health Authority's
Cancer Registration Bureau. The criteria for entry into the
historical control was the same as for the study - women
aged 45-64 years in South Nottingham and 40-64 years in
North Nottingham with breast cancer, living in the two
health districts and diagnosed immediately before the
commencement of the education programmes. Working
chronologically backwards from the date education
commenced (June 1979) the same number of women (540 in
South Nottingham and 211 in North Nottingham, total
n=751) were identified. The time periods for the 751 cancers
to arise were 96 months in the study group and 119 months
in the control.
Comparisons of tumour size, lymph node stage,
histological grade and the Nottingham prognostic index
(Haybittle et al., 1982) were made between study and
historical control groups. The prognostic index depends
upon tumour size, lymph node stage and histological grade.
In operable breast cancers, tumour size was either
pathological size after tumour fixation or the size measured
in the operating theatre on the freshly excised specimen.
Tumour grade was assessed by Dr C.W. Elston, using his
modification of the Bloom and Richardson criteria (Elston,
1987). Lymph node involvement was assessed by histological
examination of nodes sampled at the time of surgery.
Advanced breast cancer was classified by us as: locally
advanced tumour, clinical size >5.Ocm diameter or declared
clinically inoperable; patients with distant metastases at time
of presentation; or patients dying from breast cancer within
3 months of diagnosis.
Results
Attendance at education
The number of women invited to attend BSE classes during
the period 1979-1986 was 89,010, of which 37,788 attended,
a rate of 42%. A second round of invitations was sent and
approximately 7% responded to this. In the first round of
invitations approximately 15% of letters were returned as
'not known at this address'.
Attendance at self-referral clinics
In the period between 1979 and 1986 a total of 6,862
patients self-referred (Figure 1) to the two clinics. At the first
visit 4,337 were reassured and discharged. The number of
patients presenting with a true lump was 1,079; 514 of these
were cysts on aspiration, and the patient was reassured and
discharged. Of the solid lumps 274 proved to be cancer and
291 excision biopsies were performed for benign lesions.
During the 6-month review period 1,446 patients were seen,
of which 16 proved to have breast cancer and 45 excision
biopsies were carried out for benign lesions. This gives a
total of 290 cancers to 336 operations for benign lesions - a
malignant to benign operation ratio of 1:1.2.
Prognostic factors of cancers detected
There is no significant difference between the study and
historical control groups in the numbers of in situ
carcinomas - 4% in the study group and 3% in the
historical control, but there is a marginally significant
difference (P<0.05) in the rate of advanced disease - 18%
and 13% respectively. The characteristics of the tumours in
both groups are seen in Tables I and II. Significantly more
small operable tumours were detected in the study
population, and these were significantly more likely to be
node negative. There was also a significantly higher
proportion of grade I tumours in the study population -
20% compared with 13% in the historical control group
(Table III).
A total of 681 patients in the study and historical control
populations came under the care of one surgeon (RWB) and
were entered into the Nottingham/Tenovus series. It was
possible to stratify these patients into three prognostic
groups, using the Nottingham prognostic index. Three
prognostic groups of patients with different survival
probabilities are identified by this index - 'good' with a
survival probability of 88% at 5 years, 'moderate' with 69%
and 'poor' with 22%. The proportion of patients in each of
6862
(8% of population cohort)
4,337 1,079 lesions
discharged ~1,446 review (16%) {63%) (21%)
514 cysts














Figure 1 Study population - self-refer patients attending clinic 1979-1986.BREAST SELF-EXAMINATION PROGRAMME 403
Table I Study and control populations - tumour size distribution
at presentation
In situ & <2cm 2.1-5cm & advanced Not known
Study n=751 351 348 52
47% 46% 7%
Control n=751 281 402 68
37% 54% 9%
x2=11.46 (ldf); P= <0.001.
Table II Study and control populations - lymph node stage
at presentation
Operable invasive
Node-ve Node+ve Advanced Not known
Study n=751 319 235 136 61
42% 31% 18% 8%
Control n=751 250 272 101 128
33% 36% 13% 17%
x2=10.12 (I df); P= <0.01.
Table III Study and control populations - grade at
presentation
Grade I Grade II Grade III Not known
Study n=751 109 202 230 210
14% 27% 31% 28%
Control n=751 70 235 243 203
9% 31% 32% 27%
x2 = 11.3 (2df); P= <0.01.
Table IV Study and control populations - stratified by Nottingham
prognostic index
Operable
Good and in situ Moderate Poor Not applicable
Study n=751 136 200 51 364
18% 27% 7% 48%
Control n=751 78 135 73 465
1.0% 10% 10% 62%
x2=25.5 (2df); P<0.0O1.
these prognostic groups for both the study and historical
control population is seen in Table IV. There is a significant
shift towards tumours with better prognostic features in the
study population. On the basis of the prognostic groups we
have constructed predictive survival curves for the study and
control populations (Figure 2).
Case fatality
The historical control group has a follow-up range of 84-179
months, while the study group's range is 12-99 months. The
life table curves comparing the survival data of the two
groups have shown no significant difference in survival at
the present time (Figure 3). Analysis of the study population
alone, shows a significant survival advantage in case fatality
to those patients attending for education prior to their
tumour diagnosis (Figure 4).
Case control
Overall in the case-control study, approximately the same
number of women attended for education as did not attend
while proportionately less of the women dying from breast
cancer had attended for education (Table V).









Figure 2 Study and control populations








0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0
Time (years)
Number 751 535 371 237 136 69 25 (2)
at risk 751 658 578 521 469 421 376 (1)











279 197 135 82
256 174 102 54
46 19 (1)
23 6 (2)
Figure 4 Study population - attended education versus not
attended education.
on all cases (Table VI) and excluding those women in whom
breast cancer was diagnosed within 3 months of their date of
invitation to education (Table VII). This was done to
exclude those women who may have known they had breast
cancer before they received the invitation. Patients were
analysed according to their menopausal status. There is a
relative risk of dying from breast cancer of 0.66 in the post-
menopausal women attending for BSE (x2 =5.49,
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Table V Case-control study - educated versus not educated
Educated Not educated
Dead from breast cancer, n=201 80 121
Matched women not dead
from breast cancer, n=603 292 311
x2=4.01; (Idf); 0.025<P<0.05.
Table VI Case-control study - all cases, pre- and post-menopausal
Controls educated
0 1 2 3
Premenopausal
Died from breast cancer, n=50
Educated, n=25 2 10 8 5
Not educated, n=25 1 10 12 2 Controls
educated=81
Post-menoeausal
Died from breast cancer, n= 151
Educated, n=55 6 27 15 7
Not educated, n=96 15 40 31 10 Controls
educated=210
Table VII Case-control study - excluding patients diagnosed
within three months from date of entry, pre- and post-menopausal
Controls educated
0 1 2 3
Premenopausal
Died from breast cancer, n=43
Educated, n=21 2 8 6 5
Not educated, n=22 1 9 10 2 Controls
educated =70
Post-menopausal
Died from breast cancer, n=137
Educated, n=47 6 22 13 6
Nor educated, n=90 14 39 28 9 Controls
educated= 188
Table VIII Case-control study - all cases, odds ratio
Relative risk
Premenopausal 0.85 (95% confidence limits 0.45-1.60)
Post-
menopausal 0.66 (95% confidence limits 0.45-0.97)
Both 0.70 (95% confidence limits 0.50-0.97)
be seen that the beneficial effect of attendance for education
lies largely with the post-menopausal group and only
reached significance in that group (Table VIII).
Cost
The annual costs for running an average sized health district
on a BSE basis after the initial cohort had been educated
would be £15,000. This would allow for one education
session, two self-referral clinics and one session devoted to a
review clinic each week.
Discussion
In this study we found that sending a personal letter of
invitation to BSE classes over the GP's name gave much the
highest acceptance rate with over half of the women who
received an invitation for education in BSE attending.
Fifteen per cent of letters were returned as the women were
'not known at this address'. This happened in spite of the
GPs being asked to amend any known inaccuracies and has
implications for any screening programme. Of the cancers in
the study population 33% were diagnosed through the self-
referral clinics. This is despite repeated emphasis being made
on the self-referral facilities, both at the education sessions
and in the media. It would appear that many women still
continue to present to their GP in the traditional way in
greater numbers if they have an abnormality in the breast.
One of the criticisms levelled against BSE concerns the
possible unnecessary number of investigations of false
positives. BSE in our centre has been confined to the 40-64
age group and has not resulted in an unacceptable number
of benign biopsies (malignant:benign operation rates 1:0.9 in
total study group; 1: 1.2 in self-referred group). Of the 1,446
patients who were kept under review after their initial
presentation, 16 cancers were detected (1.1%). In view of
this low yield our present review policy is of dubious value
and we may alter this in future.
One major difficulty in designing a study to evaluate the
role of BSE in screening for breast cancer is that it is
impossible to avoid 'contamination' of a control group
within the same city in the current climate of widespread
BSE promotion. For this reason a group of historical
controls has been utilised for the analysis of the Nottingham
data. The UK Trial of the Early Detection of Breast Cancer
relies on control populations from areas distant from
Nottingham (UK Trial, 1981) and these results will be
published shortly. The best possible historical control group
was selected by matching the number of cancers occurring in
the health districts before and after invitation to BSE
education. The number of cases which occurred in the same
time period in the two groups is an indication that cases
have not been missed in recognising the control group.
The idea that BSE will result in finding breast cancers at
an earlier and hence more treatable stage is appealing. The
concept of BSE as a screening modality is not new. Nearly
40 years ago Haagensen suggested that since 98% of women
who developed breast cancer discovered their tumours
themselves, teaching women BSE may be of more value than
teaching the technique to physicians (Haagensen, 1950).
Feldman et al. (1981) compared tumour stage, size and
regional metastases in 1,051 breast cancer patients divided
into two groups retrospectively, with regard to BSE practice
before cancer detection. They found that women practising
BSE had detected their tumours at a smaller size and with
less lymph node involvement. Similar studies by Huguley et
al. (1981) (2,092 breast cancer patients) and Foster and
Costanza (1984) (1,004 breast cancer patients) also
retrospectively divided patients into two groups according to
their BSE practices. These results suggested that survival
rates were higher in the groups practising BSE. However,
two other retrospective studies from the USA (Saltzstein,
1984; Smith & Burns, 1985) and one prospective from the
UK (Philip et al., 1984) have not demonstrated any
difference in tumour characteristics between groups
practising BSE or not.
There are major criticisms of these studies. Both the data
regarding the histopathological tumour characteristics and
the questioning of women regarding BSE practice were often
derived retrospectively with inherent inaccuracies. They have
also been criticised because the possible confounding effects
of other breast screening modalities were not always
considered. Hill et al. (1988) used a meta-analysis of all
published studies of the effects of BSE practice. He
concluded that the evidence that BSE is a worthwhile
practice was stronger than previously thought.
The present report is the first to study prospectively the
effect of BSE on mortality from breast cancer in a closed
identified population. Prognostic factors have been recorded
and these have largely been measured at the time of
operation rather than examined at a later date. We have
shown that BSE has ameliorated the prognostic features of
the breast cancers presenting within the population. The
study group contained respectively more <2cm, node nega-
tive and well differentiated tumours than the control group.
It is disappointing and difficult to explain why there are
more advanced cancers in the study group, although theBREAST SELF-EXAMINATION PROGRAMME 405
difference is small (18% versus 13%). Tumour size, grade
and stage combined as a prognostic index demonstrate that
36% of study patients developing breast cancer lie in a good
prognostic group (potentially cured group) against 27% of
cancer cases in the control group.
The actuarial case survival curves of the study and control
populations are not significantly different at the present
time, although the median follow-up of the cancers in the
study group is only 24 months. It should be observed that
the mortality advantage in a mammographic screening
population does not become appfirent until 4-5 years from
the start of screening.
Predicted survival curves have been drawn based on the
number of patients in each prognostic index in the two
groups (Figure 2). The good group includes in situ disease
and the poor group advanced cancers. These predict a
survival advantage of 5% at 5 years for patients in the study
group. When the study population is divided on the basis of
whether they attended for education in BSE technique or not
(Figure 4) there is a clear difference, the educated group
having a 16% survival advantage at 5 years. This has been
further investigated using the case-control study, an
established method for the evaluation of screening
(Mottison, 1982; Weiss, 1983). Our case-control study was
along similar lines to those utilised in the two Dutch studies
into the value of mammographic screening (Verbeck et al.,
1984; Collette et al., 1984) and has demonstrated the value
of attendance for BSE particularly in post-menopausal
women (Tables V-VIII). This group has a highly significant
relative risk of dying of 0.66 in comparison with women who
did not attend, implying a 34% reduction in mortality in
their group. It can be argued that this difference may not
necessarily be a reflection of BSE practices; we may simply
be observing the presentation of a more health conscious
and motivated group. However, either of these
interpretations argues for a beneficial effect of earlier
presentation.
An important part of the BSE programme is the self-
referral clinics, which provide easy access to approximately
trained staff who will help to allay anxiety in the majority of
cases and immediately initiate investigations and treatment if
required.
Mammographic screening is to be introduced in the UK
over the next 3 years. Although sensitive, over 10% of breast
cancers are not detectable mammographically and 40-50%
of cancers will appear in the screening intervals with triennial
screening. It is reasonable to suggest that BSE be used as an
adjunct to mammographic screening as it may detect interval
cancers at an earlier stage. There is, in addition, a medico-
legal implication since mammography does not show every
cancer, women in the screening programme will be advised
of this and encouraged to continue to examine for physical
signs.
In conclusion, BSE is a cheap, easily taught and practised
screening modality for breast cancer. Although not as
sensitive as mammographic screening it nevertheless leads to
more favourable tumour characteristics at presentation. This
finding is emphasised by the results of the predicted survival
curves based on prognostic factors. Its particular value in
post-menopausal women is clearly relevant if BSE is to be
practised as a supplement to mammographic screening, as in
the UK the target age group will be 50-64-year-old women.
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